Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 29Neoplasms 5Glioma 4Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Glioblastoma 3Rhabdoid Tumor 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Lymphoma 2Liposarcoma 2Fallopian Tube Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Brain Neoplasms 2Astrocytoma 2Thymus Neoplasms 1Teratoma 1Solid Tumors Harboring a BRAF V600 Mutation 1Sarcoma, Synovial 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pinealoma 1Osteitis Deformans 1Oligodendroglioma 1Non functioning pancreatic endocrine tumor 1Neurofibrosarcoma 1Neuroendocrine Tumors 1

Interventions

ribociclib 1napabucasin 1bosutinib 1amrubicin 1Sunitinib 1Radiosurgery 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1Molecular Diagnostic Techniques 1Immunotherapy 1Erlotinib Hydrochloride 1Drug Therapy 1Cisplatin 1Blood Specimen Collection 1Biological Therapy 1Bevacizumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thymus Neoplasms × ribociclib × Clear all
NCT02420691 2020-10-30

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

M.D. Anderson Cancer Center

Phase 2 Completed
21 enrolled 14 charts
Gastrointestinal

Non functioning pancreatic endocrine tumor, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡